Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study. [Phase 1]

View source ↗

Summary

A Phase I clinical trial update evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of a single subcutaneous injection of HRS-9563 in subjec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HRS-9563

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Subjects With Mild Hypertension | Phase 1 | Status: RECRUITING